Eli Lilly and Company (NYSE:LLY) Given Overweight Rating at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Eli Lilly and Company (NYSE:LLY – Free Report) in a research note published on Monday morning, Benzinga reports. They currently have a $885.00 target price on the stock. A number of other research firms have also recently commented on LLY. Truist Financial reissued a buy rating […]

Leave a Reply

Your email address will not be published.

Previous post Par Pacific (NYSE:PARR) Lowered to “Hold” at Tudor, Pickering, Holt & Co.
Next post Evolus (NASDAQ:EOLS) Stock Rating Reaffirmed by Cantor Fitzgerald